To the best of our knowledge, this is the first study to link APS with MAPK/Nrf2, NF-κB and RIG-I, thus providing new perspectives regarding the mechanisms of the antioxidant activity of APS. The gene discussed is NFE2L2; the disease is autoimmune polyendocrinopathy.